News - Impax Laboratories, Legal

Filter

Current filters:

Impax LaboratoriesLegal

Popular Filters

Shire settles with Impax on Adderall XR authorized generic; initiates Ph III ABH001 study

10-02-2013

Ireland-based drugmaker Shire (LSE: SHP) says it has settled all pending litigation with Impax Laboratories…

ABH001Adderall XRDermatologicalsGenericsImpax LaboratoriesLegalNeurologicalNorth AmericaPharmaceuticalResearchShire

Endo fails in FDA law suit to stop generic Opana ER in USA; Mylan settles with Orion

21-12-2012

The US District Judge Reggie Walton, of the District Court for the District of Columbia, has dismissed…

ActavisComtanEndo PharmaceuticalsGenericsImpax LaboratoriesLegalMylan LaboratoriesNeurologicalNorth AmericaOpana ERPharmaceutical

Perrigo confirms ANDA filing for generic Astepro nasal spray

24-01-2012

US generic drugmaker Perrigo (Nasdaq: PRGO;TASE) says that it has filed an Abbreviated New Drug Application…

AsteproAzelastine HydrochlorideGenericsImpax LaboratoriesLegalMedaNorth AmericaPatentsPerrigoRegulationRespiratory and Pulmonary

Impax confirms patent challenge to GlaxoSmithKline’s Jalyn; Albemarle hikes API prices

14-09-2011

US generic drugmaker Impax Laboratories (Nasdaq: IPXL) confirms that it has initiated a challenge of…

AlbemarleAvodartGenericsGlaxoSmithKlineImpax LaboratoriesJalynLegalNorth AmericaPatentsPricing

Back to top